Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response
A low response rate limits the application of immune checkpoint inhibitors (ICIs) in the treatment of esophageal adenocarcinoma (EAC), which requires the precise characterization of heterogeneous tumor microenvironments. This study aimed to identify the molecular features and tumor microenvironment...
Saved in:
Main Authors: | Chen Ling (Author), Xiuman Zhou (Author), Yanfeng Gao (Author), Xinghua Sui (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses
by: Wenjie Zhai, et al.
Published: (2020) -
Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance
by: Wei Zhang, et al.
Published: (2023) -
Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
by: Ruijie Zeng, et al.
Published: (2021) -
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
by: Kaibo Zhu, et al.
Published: (2024) -
Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
by: Liang Sun, et al.
Published: (2023)